151 related articles for article (PubMed ID: 37350146)
1. A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial).
Qiu J; Sun S; Liu Q; Fu J; Huang Y; Hua K
J Gynecol Oncol; 2023 Sep; 34(5):e64. PubMed ID: 37350146
[TBL] [Abstract][Full Text] [Related]
2. A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial.
Wu X; Yu H; Bai Y; Hou Y; Lou W; Wang X; Zhu T; Zhang Y; Hu W; Xue X; Zhu Z; Xiang L; Li J; Fang X; Gao S; Feng H; Diao W; Zhang H; Du M; Yan W; Qiu L; Feng H; Zhu S; Du Y; Jiang H
Trials; 2023 Aug; 24(1):542. PubMed ID: 37592299
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
Zeng J; Sun P; Ping Q; Jiang S; Hu Y
PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
He M; Guo M; Zhou Q; Tang Y; Zhong L; Liu Q; Fan X; Zhao X; Zhang X; Chen G; Shen Y; Xu Q; Chen X; Li Y; Zou D
J Gynecol Oncol; 2023 May; 34(3):e55. PubMed ID: 36998225
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
Tian T; Gao X; Ju Y; Ding X; Ai Y
Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
[TBL] [Abstract][Full Text] [Related]
6. A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial.
Wu X; Qiu L; Lou W; Wang X; Zhu T; Zhang Y; Hu W; Xue X; Zhu Z; Xiang L; Li J; Fang X; Gao S; Feng H; Diao W; Zhang H; Du M; Bai Y; Hou Y; Yan W; Feng H; Yu H; Zhu S; Du Y; Jiang H
Trials; 2022 Apr; 23(1):269. PubMed ID: 35395868
[TBL] [Abstract][Full Text] [Related]
7. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.
Chakrabarti M; Nordin A; Khodabocus J
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012246. PubMed ID: 36111784
[TBL] [Abstract][Full Text] [Related]
8. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Olaitan A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD010260. PubMed ID: 35994243
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
Liu Y; Xin W; Wang P; Ji M; Guo X; Ouyang Y; Zhao D; Hua K
J Gynecol Oncol; 2024 May; 35(3):e81. PubMed ID: 38522951
[TBL] [Abstract][Full Text] [Related]
10. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Lang J; Cheng A; Li W
BMJ Open; 2019 Jul; 9(7):e029055. PubMed ID: 31362966
[TBL] [Abstract][Full Text] [Related]
13. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
15. A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.
Wu X; Feng H; Gao S; Feng H; Diao W; Zhang H; Du M; Lou W; Wang X; Zhu T; Zhang Y; Hu W; Xue X; Zhu Z; Xiang L; Li J; Fang X; Bai Y; Hou Y; Yan W; Qiu L; Yu H; Zhu S; Du Y; Jiang H
BMC Cancer; 2022 Apr; 22(1):384. PubMed ID: 35397576
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.
Tu H; Huang H; Ouyang Y; Liu Q; Xian B; Song K; Chen G; Shen Y; Liu J
Int J Gynecol Cancer; 2021 Jan; 31(1):129-133. PubMed ID: 32522771
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
Cheng J; Liu B; Wang B; Long X; Li Z; Chen R; Wu R; Xu L
BMC Cancer; 2021 Oct; 21(1):1078. PubMed ID: 34615494
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Liu J; Tang G; Zhou Q; Kuang W
Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
[TBL] [Abstract][Full Text] [Related]
19. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
20. Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery.
Yang J; Yang J; Cao D; Shen K; Ma J; Zhang F
J Gynecol Oncol; 2020 Mar; 31(2):e16. PubMed ID: 31912674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
